Increased risk of bleeding with combined use of SSRIs and antiplatelet therapy after heart attacks
Heart attack patients taking selective serotonin reuptake inhibitors (SSRIs) in combination with antiplatelet therapy -- acetylsalicylic acid (ASA), clopidogrel or both (dual antiplatelet therapy) -- are at higher risk of ...
Sep 26, 2011
0
0